Cargando…

NIR Photodynamic Destruction of PDAC and HNSCC Nodules Using Triple-Receptor-Targeted Photoimmuno-Nanoconjugates: Targeting Heterogeneity in Cancer

Receptor heterogeneity in cancer is a major limitation of molecular targeting for cancer therapeutics. Single-receptor-targeted treatment exerts selection pressures that result in treatment escape for low-receptor-expressing tumor subpopulations. To overcome this potential for heterogeneity-driven r...

Descripción completa

Detalles Bibliográficos
Autores principales: Bano, Shazia, Obaid, Girgis, Swain, Joseph W. R., Yamada, Marina, Pogue, Brian W., Wang, Kenneth, Hasan, Tayyaba
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7464411/
https://www.ncbi.nlm.nih.gov/pubmed/32726945
http://dx.doi.org/10.3390/jcm9082390
_version_ 1783577358856355840
author Bano, Shazia
Obaid, Girgis
Swain, Joseph W. R.
Yamada, Marina
Pogue, Brian W.
Wang, Kenneth
Hasan, Tayyaba
author_facet Bano, Shazia
Obaid, Girgis
Swain, Joseph W. R.
Yamada, Marina
Pogue, Brian W.
Wang, Kenneth
Hasan, Tayyaba
author_sort Bano, Shazia
collection PubMed
description Receptor heterogeneity in cancer is a major limitation of molecular targeting for cancer therapeutics. Single-receptor-targeted treatment exerts selection pressures that result in treatment escape for low-receptor-expressing tumor subpopulations. To overcome this potential for heterogeneity-driven resistance to molecular targeted photodynamic therapy (PDT), we present for the first time a triple-receptor-targeted photoimmuno-nanoconjugate (TR-PIN) platform. TR-PIN functionalization with cetuximab, holo-transferrin, and trastuzumab conferred specificity for epidermal growth factor receptor (EGFR), transferrin receptor (TfR), and human epidermal growth factor receptor 2 (HER-2), respectively. The TR-PINs exhibited up to a 24-fold improvement in cancer cell binding compared with EGFR-specific cetuximab-targeted PINs (Cet-PINs) in low-EGFR-expressing cell lines. Photodestruction using TR-PINs was significantly higher than the monotargeted Cet-PINs in heterocellular 3D in vitro models of heterogeneous pancreatic ductal adenocarcinoma (PDAC; MIA PaCa-2 cells) and heterogeneous head and neck squamous cell carcinoma (HNSCC, SCC9 cells) containing low-EGFR-expressing T47D (high TfR) or SKOV-3 (high HER-2) cells. Through their capacity for multiple tumor target recognition, TR-PINs can serve as a unique and amenable platform for the effective photodynamic eradication of diverse tumor subpopulations in heterogeneous cancers to mitigate escape for more complete and durable treatment responses.
format Online
Article
Text
id pubmed-7464411
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-74644112020-09-04 NIR Photodynamic Destruction of PDAC and HNSCC Nodules Using Triple-Receptor-Targeted Photoimmuno-Nanoconjugates: Targeting Heterogeneity in Cancer Bano, Shazia Obaid, Girgis Swain, Joseph W. R. Yamada, Marina Pogue, Brian W. Wang, Kenneth Hasan, Tayyaba J Clin Med Article Receptor heterogeneity in cancer is a major limitation of molecular targeting for cancer therapeutics. Single-receptor-targeted treatment exerts selection pressures that result in treatment escape for low-receptor-expressing tumor subpopulations. To overcome this potential for heterogeneity-driven resistance to molecular targeted photodynamic therapy (PDT), we present for the first time a triple-receptor-targeted photoimmuno-nanoconjugate (TR-PIN) platform. TR-PIN functionalization with cetuximab, holo-transferrin, and trastuzumab conferred specificity for epidermal growth factor receptor (EGFR), transferrin receptor (TfR), and human epidermal growth factor receptor 2 (HER-2), respectively. The TR-PINs exhibited up to a 24-fold improvement in cancer cell binding compared with EGFR-specific cetuximab-targeted PINs (Cet-PINs) in low-EGFR-expressing cell lines. Photodestruction using TR-PINs was significantly higher than the monotargeted Cet-PINs in heterocellular 3D in vitro models of heterogeneous pancreatic ductal adenocarcinoma (PDAC; MIA PaCa-2 cells) and heterogeneous head and neck squamous cell carcinoma (HNSCC, SCC9 cells) containing low-EGFR-expressing T47D (high TfR) or SKOV-3 (high HER-2) cells. Through their capacity for multiple tumor target recognition, TR-PINs can serve as a unique and amenable platform for the effective photodynamic eradication of diverse tumor subpopulations in heterogeneous cancers to mitigate escape for more complete and durable treatment responses. MDPI 2020-07-27 /pmc/articles/PMC7464411/ /pubmed/32726945 http://dx.doi.org/10.3390/jcm9082390 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Bano, Shazia
Obaid, Girgis
Swain, Joseph W. R.
Yamada, Marina
Pogue, Brian W.
Wang, Kenneth
Hasan, Tayyaba
NIR Photodynamic Destruction of PDAC and HNSCC Nodules Using Triple-Receptor-Targeted Photoimmuno-Nanoconjugates: Targeting Heterogeneity in Cancer
title NIR Photodynamic Destruction of PDAC and HNSCC Nodules Using Triple-Receptor-Targeted Photoimmuno-Nanoconjugates: Targeting Heterogeneity in Cancer
title_full NIR Photodynamic Destruction of PDAC and HNSCC Nodules Using Triple-Receptor-Targeted Photoimmuno-Nanoconjugates: Targeting Heterogeneity in Cancer
title_fullStr NIR Photodynamic Destruction of PDAC and HNSCC Nodules Using Triple-Receptor-Targeted Photoimmuno-Nanoconjugates: Targeting Heterogeneity in Cancer
title_full_unstemmed NIR Photodynamic Destruction of PDAC and HNSCC Nodules Using Triple-Receptor-Targeted Photoimmuno-Nanoconjugates: Targeting Heterogeneity in Cancer
title_short NIR Photodynamic Destruction of PDAC and HNSCC Nodules Using Triple-Receptor-Targeted Photoimmuno-Nanoconjugates: Targeting Heterogeneity in Cancer
title_sort nir photodynamic destruction of pdac and hnscc nodules using triple-receptor-targeted photoimmuno-nanoconjugates: targeting heterogeneity in cancer
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7464411/
https://www.ncbi.nlm.nih.gov/pubmed/32726945
http://dx.doi.org/10.3390/jcm9082390
work_keys_str_mv AT banoshazia nirphotodynamicdestructionofpdacandhnsccnodulesusingtriplereceptortargetedphotoimmunonanoconjugatestargetingheterogeneityincancer
AT obaidgirgis nirphotodynamicdestructionofpdacandhnsccnodulesusingtriplereceptortargetedphotoimmunonanoconjugatestargetingheterogeneityincancer
AT swainjosephwr nirphotodynamicdestructionofpdacandhnsccnodulesusingtriplereceptortargetedphotoimmunonanoconjugatestargetingheterogeneityincancer
AT yamadamarina nirphotodynamicdestructionofpdacandhnsccnodulesusingtriplereceptortargetedphotoimmunonanoconjugatestargetingheterogeneityincancer
AT poguebrianw nirphotodynamicdestructionofpdacandhnsccnodulesusingtriplereceptortargetedphotoimmunonanoconjugatestargetingheterogeneityincancer
AT wangkenneth nirphotodynamicdestructionofpdacandhnsccnodulesusingtriplereceptortargetedphotoimmunonanoconjugatestargetingheterogeneityincancer
AT hasantayyaba nirphotodynamicdestructionofpdacandhnsccnodulesusingtriplereceptortargetedphotoimmunonanoconjugatestargetingheterogeneityincancer